Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
|
|
Gene Biotherapeutics, Inc. (CRXM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/28/2021 |
4
| Jemapete Christopher J (10% Owner) has filed a Form 4 on Gene Biotherapeutics, Inc. |
| 03/18/2021 |
4
| Jemapete Christopher J (10% Owner) has filed a Form 4 on Gene Biotherapeutics, Inc.|
Txns:
| Bought 300,000 shares
@ $0.0399, valued at
$12k
Bought 200,000 shares
@ $0.402, valued at
$80.4k
|
|
| 03/27/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2015 |
4
| Gabrielson Edward W (Director) has filed a Form 4 on Taxus Cardium Pharmaceuticals Group Inc. |
| 03/27/2015 |
4
| Otremba Lon E (Director) has filed a Form 4 on Taxus Cardium Pharmaceuticals Group Inc. |
| 03/27/2015 |
4
| HUTCHISON MURRAY H (Director) has filed a Form 4 on Taxus Cardium Pharmaceuticals Group Inc.|
Txns:
| Acquired 50,000 options to buy
@ $0.6, valued at
$30k
|
|
| 03/27/2015 |
4
| Leitch Andrew M (Director) has filed a Form 4 on Taxus Cardium Pharmaceuticals Group Inc.|
Txns:
| Acquired 50,000 options to buy
@ $0.6, valued at
$30k
|
|
| 03/27/2015 |
4
| REINHARD CHRISTOPHER J (CEO) has filed a Form 4 on Taxus Cardium Pharmaceuticals Group Inc.|
Txns:
| Acquired 400,000 options to buy
@ $0.6, valued at
$240k
|
|
| 03/04/2014 |
4
| LEWIS GERALD J (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/04/2014 |
4
| REINHARD CHRISTOPHER J (CEO) has filed a Form 4 on Cardium Therapeutics, Inc.|
Txns:
| Acquired 548,550 options to buy
@ $0.8, valued at
$438.8k
Acquired 548,550 options to buy
@ $0.8, valued at
$438.8k
|
|
| 03/04/2014 |
4
| Otremba Lon E (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/04/2014 |
4
| HUTCHISON MURRAY H (Director) has filed a Form 4 on Cardium Therapeutics, Inc.|
Txns:
| Acquired 50,000 options to buy
@ $0.8, valued at
$40k
|
|
| 03/04/2014 |
4
| Leitch Andrew M (Director) has filed a Form 4 on Cardium Therapeutics, Inc.|
Txns:
| Acquired 50,000 options to buy
@ $0.8, valued at
$40k
|
|
| 03/04/2014 |
4
| Gabrielson Edward W (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/04/2014 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/04/2014 |
4
| Rubanyi Gabor M (Chief Scientific Officer) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/04/2014 |
4
| Dylan Tyler Michael (Chief Business Officer) has filed a Form 4 on Cardium Therapeutics, Inc.|
Txns:
| Acquired 448,550 options to buy
@ $0.8, valued at
$358.8k
Acquired 448,550 options to buy
@ $0.8, valued at
$358.8k
|
|
| 06/15/2009 |
4
| Rubanyi Gabor M (Chief Scientific Officer) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/18/2009 |
4
| Leitch Andrew M (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/17/2009 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/17/2009 |
4
| Gabrielson Edward W (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/17/2009 |
4
| Otremba Lon E (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/17/2009 |
4
| LEWIS GERALD J (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 03/17/2009 |
4
| HUTCHISON MURRAY H (Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
| 02/02/2009 |
4
| SIMON RONALD I (Former Director) has filed a Form 4 on Cardium Therapeutics, Inc. |
|
|